Moderna (MRNA) Earnings Date, Estimates & Call Transcripts $26.20 +1.70 (+6.94%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$26.32 +0.12 (+0.46%) As of 04/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Moderna Earnings Summary Upcoming Q4 Earnings DateMay. 1Before Market OpensEstimatedConsensus EPS (Nov. 7) -$1.89 Actual EPS (Nov. 7) $0.03 Beat By $1.92 Actual Revenue (Nov. 7) $1.90BModerna issued Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.03, which beat analysts' consensus estimates of -$1.89 by $1.92. Quarterly revenue rose 3.8% year-over-year to $1.90 billion, above analyst estimates of $1.25 billion. With a trailing EPS of -$9.28, Moderna's earnings are expected to grow next year, from ($9.61) to ($6.59) per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)MRNA Upcoming EarningsModerna's Q1 2025 earnings is scheduled for Thursday, May 1, 2025, with a conference call scheduled at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Moderna Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Moderna and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMRNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MRNA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Moderna Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$2.90-$2.58-$2.78Q2 20253-$3.11-$2.56-$2.75Q3 20253-$2.55-$0.83-$1.61Q4 20253-$2.54-$0.49-$1.43FY 202512-$11.10-$6.46-$8.57Q1 20261-$2.68-$2.68-$2.68Q2 20261-$2.76-$2.76-$2.76Q3 20261-$0.72-$0.72-$0.72 Remove Ads Moderna Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/1/2025(Estimated)-------11/7/2024Q3 2024-$1.89$0.03+$1.92$0.03$1.25B$1.90B8/1/2024Q2 2024-$3.47-$3.33+$0.14-$3.33$128.41M$241.00M5/2/2024Q1 2024-$3.59-$3.07+$0.52-$3.07$93.26M$167.00M2/22/2024Q4 2023-$0.78$0.55+$1.33$0.55$2.53B$2.80B11/2/2023Q3 2023-$2.01-$1.39+$0.62$6.75$1.37B$1.83B8/3/2023Q2 2023-$3.84-$3.62+$0.22-$3.62$307.67M$344.00M5/4/2023Q1 2023-$1.77$0.19+$1.96$0.19$1.17B$1.86B Moderna Earnings - Frequently Asked Questions When is Moderna's earnings date? Moderna has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on MRNA's earnings history. What guidance has Moderna issued on next quarter's earnings? Moderna updated its FY 2025 earnings guidance on Friday, February, 14th. The company issued revenue guidance of $1.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.2 billion. Did Moderna beat their earnings estimates last quarter? In the previous quarter, Moderna (NASDAQ:MRNA) reported $0.03 earnings per share (EPS) to beat the analysts' consensus estimate of ($1.89) by $1.92. Learn more on analysts' earnings estimate vs. MRNA's actual earnings. How can I listen to Moderna's earnings conference call? The conference call for Moderna's latest earnings report can be listened to online. Listen to Conference Call How can I read Moderna's conference call transcript? The conference call transcript for Moderna's latest earnings report can be read online. Read Transcript How much revenue does Moderna generate each year? Moderna (NASDAQ:MRNA) has a recorded annual revenue of $3.20 billion. How much profit does Moderna generate each year? Moderna (NASDAQ:MRNA) has a recorded net income of -$3.56 billion. MRNA has generated -$9.28 earnings per share over the last four quarters. What is Moderna's EPS forecast for next year? Moderna's earnings are expected to grow from ($9.61) per share to ($6.59) per share in the next year. More Earnings Resources from MarketBeat Related Companies argenx Earnings Date Beigene Earnings Date BioNTech Earnings Date Teva Pharmaceutical Industries Earnings Date Intra-Cellular Therapies Earnings Date Summit Therapeutics Earnings Date Genmab A/S Earnings Date Dr. Reddy's Laboratories Earnings Date Viatris Earnings Date Qiagen Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:MRNA) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersThe rotation into gold miners is on.They’re deeply undervalued gold developers with massive in-the-ground, proven resources - and now, fast-track ...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWARNING to All American InvestorsForget the headlines about the "trade war." This is where a real military showdown between China and the U....Behind the Markets | SponsoredDOGE’s 690% winning stockElon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRNA Stock Free MRNA Stock Alerts